In this episode, Ayesha spoke with Adam Grant, PhD, Principal Scientist at CancerVax, to discuss the company’s Universal Cancer Treatment Platform.

The immunotherapy tool uses AI to train the immune system to recognize and eliminate cancer cells by modifying those cells to resemble known pathogens like measles. This innovative approach prompts a stronger and more effective immune response compared to traditional immunotherapies.

Dr. Grant, a leading computational biologist and one of the inventors behind the platform, shares insights into how AI and next-generation sequencing are revolutionizing fields like cancer immunotherapy.

Dr. Grant previously served as a Bioinformatician at Xenter Medical Technologies and as a Computational Scientist at RAPT Therapeutics. His innovations include software designed to improve cancer antigen detection and a gene-signature approach for selecting treatments for breast cancer.

Dr. Grant earned a Bachelor of Science (BSc) in Bioinformatics from Brigham Young University and a PhD in Cancer Biology with an emphasis in Bioinformatics from the University of Arizona.

From discovering new drug targets to engineering smarter immune strategies, tune in to hear Dr. Grant discuss how bioinformatics is reshaping innovations in cancer immunotherapy.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media

Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

In this episode, Vera spoke with Dr. Alessandra Maleddu, a medical oncologist and sarcoma specialist at the University of Colorado. Dr. Maleddu specializes in soft tissue and bone sarcomas, with a particular focus on desmoid tumors and advancing clinical trials in this rare disease area.

Desmoid tumors are locally invasive soft tissue tumors that present unique diagnostic and treatment challenges, as they can vary significantly from patient to patient and are often misdiagnosed. Women are two to three times more likely than men to be diagnosed with a desmoid tumor.

Dr. Maleddu trained in Italy and the UK, completing a sarcoma fellowship at University College London Hospital, general oncology training at the University of Bologna and earning her MD from the University of Cagliari in Italy.

Tune in to hear how Dr. Maleddu is helping lead in the sarcoma space, with a focus on desmoid tumors.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media

Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

In this episode, Vera spoke with Jay Hartenbach, President and Chief Operating Officer of Diakonos Oncology, a company developing cancer immunotherapies to address the critical and unmet medical need of late-stage and aggressive cancers like glioblastoma.

Jay is a passionate advocate for wellness and innovative healthcare, bringing a unique blend of scientific knowledge, entrepreneurial enthusiasm and business strategy expertise to the Life Sciences industry.

He concurrently serves as the COO of another cancer immunotherapy company, Immunocine. Before moving to biotech, Jay co-founded wellness company Medterra, where he continues to shape the company’s strategic direction as Chairman of the Board. Jay also co-founded Perland Pharmaceuticals, an early-stage biotech company actively developing therapies for arthritis conditions.

Jay has a Masters in Engineering Management from Duke University and a Bachelor of Science in Biomedical Engineering from the University of Miami.

Tune into the episode to hear how Jay is helping drive new frontiers in cancer immunotherapy at Diakonos Oncology through scientific innovation and strategic leadership.

For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media

Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured